ERS Genomics completes licensing agreement with Syngene International
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Subscribe To Our Newsletter & Stay Updated